Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Po Chai Pills is a renowned Proprietary Chinese Medicine (PCM) used primarily for the relief of gastrointestinal distress. Originally developed in 1896 by Li Chung Shing Tong (now a subsidiary of JBM Healthcare), the formulation is a complex blend of approximately 14 herbal ingredients, including *Poria cocos*, *Angelica dahurica*, and *Magnolia officinalis*. It is indicated for the treatment of indigestion, nausea, vomiting, diarrhea, bloating, and motion sickness. The product is widely available as an over-the-counter (OTC) remedy in Southeast Asia and is typically administered orally in the form of small, spherical pills packaged in glass vials. Its therapeutic effects are attributed to the synergistic action of its botanical components in regulating digestive function and alleviating gastrointestinal discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Po Chai Pills.